Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and cerebrovascular diseases: a meta-analysis of controlled clinical trials.
鈉-葡萄糖共轉運蛋白 2 抑制劑對心血管和腦血管疾病的影響:一項受控臨床試驗的 meta-analysis。
Front Endocrinol (Lausanne) 2024-09-09
Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials.
與心血管結果和安全事件相關的鈉葡萄糖共轉運蛋白2抑制劑:隨機對照臨床試驗的荟萃分析。
Front Cardiovasc Med 2022-11-02
Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients With Diabetes and Chronic Kidney Disease (CKD): A Meta-analysis of Randomized Control Trials.
SGLT2抑制劑在糖尿病和慢性腎臟病患者中的療效和安全性:隨機對照試驗的荟萃分析。
Cureus 2023-01-03
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials.
SGLT2抑制劑在心衰患者和非心衰患者心血管結果中的臨床效力:一項隨機試驗的系統性回顧和荟萃分析。
Medicine (Baltimore) 2023-01-11
SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials.
SGLT2 抑制劑用於預防原發性和次發性心血管結果:隨機對照試驗的荟萃分析。
Heart Lung 2023-10-12
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.
背景心血管藥物對鈉葡萄糖共同轉運蛋白-2抑製劑的影響:系統性回顧與荟萃分析。
Diabetes Obes Metab 2023-09-05
Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
腎功能不同對鈉葡萄糖共轉運蛋白2抑制劑在心血管和腎臟結果上的差異影響:涉及10個隨機臨床試驗和71,553名個體的劑量反應荟萃分析。
Eur J Endocrinol 2023-08-04
Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review.
二型糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑與心血管保護:系統性回顧。
J Diabetes Res 2024-05-20
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.
SGLT2 抑制劑對心衰結果和心血管死亡的影響:跨心臟代謝疾病譜的系統性回顧和荟萃分析。
Lancet Diabetes Endocrinol 2024-05-20
Cardiovascular Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Updated Meta-Analysis.
二型糖尿病合併慢性腎臟病患者接受鈉葡萄糖共同轉運蛋白2抑制劑治療的心血管結果:系統性回顧與更新的荟萃分析。
Korean Circ J 2024-06-11
Cardioprotective effects of sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase 4 inhibitor in type 2 diabetes: A meta-analysis of comparative safety and efficacy.
二型糖尿病中鈉葡萄糖共轉運蛋白 2 抑制劑與二肽基肽酶 4 抑制劑的心臟保護效果:一項比較安全性和療效的 meta-analysis。
SAGE Open Med 2024-07-29